TP53 and urothelial carcinoma: p53 overexpression in the nucleus has been shown not only to correlate with progression and recurrence of urothelial carcinoma but also to be useful in distinguishing urothelial carcinoma in situ from reactive urothelial atypia.6, 7, 8